Qingxin X. Xia
No.127 Dongming Road
Zhengzhou, 450008, China
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
The Potential Role of Tumor Microorganisms in Remodeling Tumor Biomechanical Signals and Application Strategies in Tumor Therapy.
Journal: Microorganisms
Published: March 08, 2026
Clinicopathological, prognostic, and molecular differences between microsatellite-stable colorectal cancer patients aged ≤ 30 years and > 30 years.
Journal: BMC cancer
Published: December 18, 2025
Contrast-enhanced MRI improves the diagnostic performance for vaginal fornix invasion in cervical carcinoma.
Journal: Insights into imaging
Published: November 22, 2025
Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study.
Journal: BMC medicine
Published: October 15, 2025
Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan-Tumor.
Journal: Cancer innovation
Published: August 12, 2025
Mutational landscape and risk estimates of DDR genes in Chinese ovarian cancer patients.
Journal: Journal of ovarian research
Published: July 02, 2025
Integrated microbiome-metabolome profiling unveils a predictive signature for early recurrence in hepatocellular carcinoma.
Journal: Frontiers in microbiology
Published: June 24, 2025
Retraction Note: Overexpression of LncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells.
Journal: Cancer cell international
Published: June 06, 2025
Heterogeneity and distribution characteristics of tertiary lymphoid structures predict prognostic outcome in esophageal squamous cell carcinoma.
Journal: Frontiers in immunology
Published: April 05, 2025
Application of Neoadjuvant Docetaxel plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 24, 2025
Neoadjuvant camrelizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma: a single-arm, phase 2 trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: January 17, 2025
Last Updated: 09/26/2026